Fig. 3From: Response to targeted therapy or chemotherapy following immunotherapy in patients with gastrointestinal cancers - a case seriesa: Computed Tomography (CT) scan in February after treatment with a PD-L1 inhibitor. b: CT scan showing smaller lesions in April 2018 after treatment with SorafenibBack to article page
